Dual-Responsive Multi-Functional Silica Nanoparticles With Repaired Mitochondrial Functions for Efficient Alleviation of Spinal Cord Injury

Abstract

Preserved/rescued mitochondrial functions have a significant effect on maintaining neurogenesis, axonal carriage, and synaptic plasticity following spinal cord injury (SCI). We fabricated an ingenious redox-responsive strategy for commanded liberation of NADH (reduced form of nicotinamide-adenine dinucleotide) by bioactive diselenide-containing biodegradable mesoporous silica nanoparticles (Se@NADH). The nanocarrier-embedded NADH can be liberated in a controlled pattern through the cleavage of diselenide bonds in the presence of reactive oxygen species (ROS) or glutathione (GSH). The NAD⁺ was regenerated by the reactions between released NADH and harmful ROS to antagonize mitochondrial dysfunction and increase ATP synthesis, promoting axon regeneration across SCI areas. This nanosystem increased the stability of NADH during prolonged blood circulation time, reduced the clearance rate, exhibited significant anti-inflammatory as well as neuroprotective effects and enhanced the regeneration of electrophysiological conduction capacity across SCI areas. Importantly, Se@NADH suppressed glial scar formation and promoted neuronal generation as well as stretching of long axons throughout the glial scar, thereby improving actual restoration of locomotor functions in mice with SCI and exerting ascendant therapeutic effects. Targeting of mitochondrial dysfunction is a potential approach for SCI treatment and may be applied to other central nervous system diseases.

Keywords

diselenide-containing mesoporous silica nanoparticles / mitochondrial functions / nanocarrier / redox-responsive / spinal cord injury

References

[1] M. A. Anderson, T. M. O'Shea, J. E. Burda, et al., “Required Growth Facilitators Propel Axon Regeneration Across Complete Spinal Cord Injury,” Nature 561, no. 7723 (2018): 396-400.

[2] J. Ruschel, F. Hellal, K. C. Flynn, et al., “Systemic Administration of Epothilone B Promotes Axon Regeneration After Spinal Cord Injury,” Science 348, no. 6232 (2015): 347-352.

[3] S. Thuret, L. Moon, and F. Gage, “Therapeutic Interventions After Spinal Cord Injury,” Nature Reviews Neuroscience 7, no. 8 (2006): 628-643.

[4] D. Su, Z. Jiao, S. Li, et al., “Frontispiece: Spatiotemporal Single-cell Transcriptomic Profiling Reveals Inflammatory Cell States in a Mouse Model of Diffuse Alveolar Damage (EXP2 3/2023),” Exploration 3, no. 3 (2023): 20210486.

[5] Y. Zhang, Y. Xu, H. Kong, et al., “Microneedle System for Tissue Engineering and Regenerative Medicine,” Exploration 3, no. 1 (2023): 20210170.

[6] Y. Zhang, Z. Zou, S. Liu, et al., “Edaravone-Loaded Poly(amino acid) Nanogel Inhibits Ferroptosis for Neuroprotection in Cerebral Ischemia Injury,” Asian Journal of Pharmaceutical Sciences 19, no. 2 (2024): 100886.

[7] Q. Zhang, B. Shi, J. Ding, et al., “Polymer Scaffolds Facilitate Spinal Cord Injury Repair,” Acta Biomaterialia 88 (2019): 57-77.

[8] X. Wan, Y. Zhao, Z. Li, and L. Li, “Emerging Polymeric Electrospun Fibers: From Structural Diversity to Application in Flexible Bioelectronics and Tissue Engineering,” Exploration 2, no. 1 (2022): 20210029.

[9] S. Liu, S. Fu, G. Wang, et al., “Glycerol-3-Phosphate Biosynthesis Regenerates Cytosolic NAD⁺ to Alleviate Mitochondrial Disease,” Cell Metabolism 33, no. 10 (2021): 1974-1987.e9.

[10] R. Iwata, P. Casimir, E. Erkol, et al., “Mitochondria Metabolism Sets the Species-Specific Tempo of Neuronal Development,” Science 379, no. 6632 (2023): eabn4705.

[11] L. M. Marquardt, V. M. Doulames, A. T. Wang, et al., “Designer, Injectable Gels to Prevent Transplanted Schwann Cell Loss During Spinal Cord Injury Therapy,” Science Advances 6, no. 14 (2020): eaaz1039.

[12] M. T. Lin and M. F. Beal, “Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases,” Nature 443, no. 7113 (2006): 787-795.

[13] A. P. Tran and J. Silver, “Systemically Treating Spinal Cord Injury,” Science 348, no. 6232 (2015): 285-286.

[14] W. Zhang, H. Chen, L. Ding, et al., “Microglial Targeted Therapy Relieves Cognitive Impairment Caused by Cntnap4 Deficiency,” Exploration 3, no. 3 (2023): 20220160.

[15] H. Peng, F. Yao, J. Zhao, et al., “Inside Front Cover: Unraveling Mitochondria-targeting Reactive Oxygen Species Modulation and Their Implementations in Cancer Therapy by Nanomaterials (EXP2 2/2023),” Exploration 3, no. 2 (2023): 20210472.

[16] M. F. Beal, “Mitochondrial Dysfunction in Neurodegenerative Diseases,” BBA-Bioenergetics 1366, no. 1-2 (1998): 211-223.

[17] A. Trifunovic and N. G. Larsson, “Mitochondrial Dysfunction as a Cause of Ageing,” Journal of Internal Medicine 263, no. 2 (2008): 167-178.

[18] S. W. Ballinger, “Mitochondrial Dysfunction in Cardiovascular Disease,” Free Radical Biology and Medicine 38, no. 10 (2005): 1278-1295.

[19] Z. Álvarez, A. N. Kolberg-Edelbrock, I. R. Sasselli, et al., “Bioactive Scaffolds With Enhanced Supramolecular Motion Promote Recovery From Spinal Cord Injury,” Science 374, no. 6569 (2021): 848-856.

[20] P. G. Sullivan, S. Krishnamurthy, S. P. Patel, J. D. Pandya, and A. G. Rabchevsky, “Temporal Characterization of Mitochondrial Bioenergetics After Spinal Cord Injury,” Journal of Neurotrauma 24, no. 6 (2007): 991-999.

[21] Y. Jiang, P. Fu, Y. Liu, et al., “Near-Infrared Light-Triggered no Release for Spinal Cord Injury Repair,” Science Advances 6, no. 39 (2020): eabc3513.

[22] K. Birsoy, T. Wang, W. W. Chen, E. Freinkman, M. Abu-Remaileh, and D. M. Sabatini, “An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis,” Cell 162, no. 3 (2015): 540-551.

[23] R. Cerutti, E. Pirinen, C. Lamperti, et al., “NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease,” Cell Metabolism 19, no. 6 (2014): 1042-1049.

[24] R. P. Goodman, A. L. Markhard, H. Shah, et al., “Hepatic NADH Reductive Stress Underlies Common Variation in Metabolic Traits,” Nature 583, no. 7814 (2020): 122-126.

[25] A. P. Gomes, N. L. Price, A. J. Ling, et al., “Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication During Aging,” Cell 155, no. 7 (2013): 1624-1638.

[26] E. Katsyuba, M. Romani, D. Hofer, and J. Auwerx, “NAD+ Homeostasis in Health and Disease,” Nature Metabolism 2, no. 1 (2020): 9-31.

[27] W. Kim, A. Deik, C. Gonzalez, et al., “Polyunsaturated Fatty Acid Desaturation is a Mechanism for Glycolytic NAD+ Recycling,” Cell Metabolism 29, no. 4 (2019): 856-870.e7.

[28] D. Shao, M. Li, Z. Wang, et al., “Bioinspired Diselenide-Bridged Mesoporous Silica Nanoparticles for Dual-Responsive Protein Delivery,” Advanced Materials 30, no. 29 (2018): 1801198.

[29] Q. Zhang, C. Shen, N. Zhao, and F.-J. Xu, “Redox-Responsive and Drug-Embedded Silica Nanoparticles With Unique Self-Destruction Features for Efficient Gene/Drug Codelivery,” Advanced Functional Materials 27, no. 10 (2017): 1606229.

[30] Y. Wang, L. Zhu, Y. Wang, et al., “Ultrasensitive GSH-Responsive Ditelluride-Containing Poly(ether-urethane) Nanoparticles for Controlled Drug Release,” ACS Applied Materials & Interfaces 8, no. 51 (2016): 35106-35113.

[31] L. Guo, H. Chen, J. Ding, P. Rong, M. Sun, and W. Zhou, “Surface Engineering Salmonella With pH-responsive Polyserotonin and Self-activated DNAzyme for Better Microbial Therapy of Tumor,” Exploration 3, no. 6 (2023): 20230017.

[32] S. Theivendran, S. Lazarev, and C. Yu, “Mesoporous Silica/Organosilica Nanoparticles for Cancer Immunotherapy,” Exploration 3, no. 3 (2023): 20220086.

[33] D. V. Titov, V. Cracan, R. P. Goodman, J. Peng, Z. Grabarek, and V. K. Mootha, “Complementation of Mitochondrial Electron Transport Chain by Manipulation of the NAD+/NADH Ratio,” Science 352, no. 6282 (2016): 231-235.

[34] C. F. Lee, A. Caudal, L. Abell, G. A. Nagana Gowda, and R. Tian, “Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease,” Scientific Reports 9, no. 1 (2019): 3073.

[35] S. Rao, Y. Lin, R. Lin, et al., “Traditional Chinese Medicine Active Ingredients-Based Selenium Nanoparticles Regulate Antioxidant Selenoproteins for Spinal Cord Injury Treatment,” Journal of Nanobiotechnology 20, no. 1 (2022): 278.

[36] S. Hariharan and S. Dharmaraj, “Selenium and Selenoproteins: It's Role in Regulation of Inflammation,” Inflammopharmacology 28, no. 3 (2020): 667-695.

[37] J. C. Avery and P. R. Hoffmann, “Selenium, Selenoproteins, and Immunity,” Nutrients 10, no. 9 (2018): 1203.

[38] Z.-S. Ji, G.-B. Gao, Y.-M. Ma, et al., “Highly Bioactive Iridium Metal-Complex Alleviates Spinal Cord Injury via ROS Scavenging and Inflammation Reduction,” Biomaterials 284 (2022): 121481.

[39] W. Zhang, W. Lin, X. Zheng, S. He, and Z. Xie, “Comparing Effects of Redox Sensitivity of Organic Nanoparticles to Photodynamic Activity,” Chemistry of Materials 29, no. 4 (2017): 1856-1863.

[40] H. Xu, W. Cao, and X. Zhang, “Selenium-Containing Polymers: Promising Biomaterials for Controlled Release and Enzyme Mimics,” Accounts of Chemical Research 46, no. 7 (2013): 1647-1658.

[41] C. M. Weekley and H. H. Harris, “Which Form Is That? The Importance of Selenium Speciation and Metabolism in the Prevention and Treatment of Disease,” Chemical Society Reviews 42, no. 23 (2013): 8870-8894.

[42] W. Hou and H. Xu, “Incorporating Selenium Into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities,” Journal of Medicinal Chemistry 65, no. 6 (2022): 4436-4456.

[43] H. Sies and D. P. Jones, “Reactive Oxygen Species (ROS) as Pleiotropic Physiological Signalling Agents,” Nature Reviews Molecular Cell Biology 21, no. 7 (2020): 363-383.

[44] N. P. Visavadiya, S. P. Patel, J. L. VanRooyen, P. G. Sullivan, and A. G. Rabchevsky, “Cellular and Subcellular Oxidative Stress Parameters Following Severe Spinal Cord Injury,” Redox Biology 8 (2016): 59-67.

[45] X. Ge, P. Tang, Y. Rong, et al., “Exosomal miR-155 From M1-polarized Macrophages Promotes EndoMT and Impairs Mitochondrial Function via Activating NF-κB Signaling Pathway in Vascular Endothelial Cells After Traumatic Spinal Cord Injury,” Redox Biology 41 (2021): 101932.

[46] S. S. Andrabi, J. Yang, Y. Gao, Y. Kuang, and V. Labhasetwar, “Nanoparticles With Antioxidant Enzymes Protect Injured Spinal Cord From Neuronal Cell Apoptosis by Attenuating Mitochondrial Dysfunction,” Journal of Controlled Release 317 (2020): 300-311.

[47] M. Khacho, A. Clark, D. S. Svoboda, et al., “Mitochondrial Dynamics Impacts Stem Cell Identity and Fate Decisions by Regulating a Nuclear Transcriptional Program,” Cell Stem Cell 19, no. 2 (2016): 232-247.

[48] Z. Ye, C. Hu, J. Wang, et al., “Burst of Hopping Trafficking Correlated Reversible Dynamic Interactions Between Lipid Droplets and Mitochondria Under Starvation,” Exploration 3, no. 5 (2023): 20230002.

[49] G. S. McElroy, C. R. Reczek, P. A. Reyfman, D. S. Mithal, C. M. Horbinski, and N. S. Chandel, “NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction,” Cell Metabolism 32, no. 2 (2020): 301-308.e6.

[50] D. Jiang, F. Gong, X. Ge, et al., “Neuron-Derived Exosomes-Transmitted miR-124-3p Protect Traumatically Injured Spinal Cord by Suppressing the Activation of Neurotoxic Microglia and Astrocytes,” Journal of Nanobiotechnology 18, no. 1 (2020): 1-20.

[51] S. Herold, P. Kumar, K. Jung, et al., “CatWalk Gait Analysis in a Rat Model of Multiple Sclerosis,” BMC Neuroscience 17, no. 1 (2016): 78.

[52] M. Bonizzato and M. Martinez, “An Intracortical Neuroprosthesis Immediately Alleviates Walking Deficits and Improves Recovery of Leg Control After Spinal Cord Injury,” Science Translational Medicine 13, no. 586 (2021): eabb4422.

[53] L. Mayo, S. A. Trauger, M. Blain, et al., “Regulation of Astrocyte Activation by Glycolipids Drives Chronic CNS Inflammation,” Nature Medicine 20, no. 10 (2014): 1147-1156.

[54] J. W. Kim, C. Mahapatra, J. Y. Hong, et al., “Functional Recovery of Contused Spinal Cord in Rat With the Injection of Optimal-Dosed Cerium Oxide Nanoparticles,” Advancement of Science 4, no. 10 (2017): 1700034.

[55] Y. Gao, S. Vijayaraghavalu, M. Stees, B. K. Kwon, and V. Labhasetwar, “Evaluating Accessibility of Intravenously Administered Nanoparticles at the Lesion Site in Rat and Pig Contusion Models of Spinal Cord Injury,” Journal of Controlled Release 302 (2019): 160-168.

RIGHTS & PERMISSIONS

2025 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.